Miriplatin (SM-11355) is a chemotherapy agent which belongs to the class of alkylating agents.
性状
Solid
体外研究(In Vitro)
Miriplatin (SM-11355) suspended in LPD (miriplatin/LPD, 100 μg/mL) inhibits the growth of AH109A cells, forms platinum-DNA adducts, and induces apoptosis. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Miriplatin (SM-11355) (0.02-0.4 mg/20 μL) in lipiodol reduces tumor growth rates in a dose dependent manner in rats bearing AH109A tumor cells. Miriplatin/LPD (400 μg/head) significantly reduces the growth of tumor in rats bearing AH109A cells. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Kishimoto S, et al. Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration. Biol Pharm Bull. 2000 Mar;23(3):344-8.[2]. Hanada M, et al. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmaco
溶解度数据
In Vitro: Acetone : < 1 mg/mL (ultrasonic) (insoluble; DMSO can inactivate Miriplatins activity)DMF : < 1 mg/mL (insoluble; DMSO can inactivate Miriplatins activity)H2O : < 0.1 mg/mL (insoluble; DMSO can inactivate Miriplatins activity) Miriplatin is usually formulated as a suspension.